Tirzepatide Scores Win in Second Obesity Trial, SURMOUNT-2 ...Middle East

News by : (Medscape) -
The "twincretin" tirzepatide (Mounjaro) met its primary endpoints compared with placebo in the SURMOUNT-2 trial, designed to test weight loss efficacy, in top-line results reported by Lilly. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Tirzepatide Scores Win in Second Obesity Trial, SURMOUNT-2 )

Also on site :

Most Viewed News
جديد الاخبار